. Although recent advances have improved our ability to document cellular phenotypic variation [4] [5] [6] [7] [8] , the fundamental mechanisms that generate variability from identical DNA sequences remain elusive. Here we reveal the landscape and principles of mammalian DNA regulatory variation by developing a robust method for mapping the accessible genome of individual cells by assay for transposase-accessible chromatin using sequencing (ATAC-seq) 9 integrated into a programmable microfluidics platform. Single-cell ATAC-seq (scATAC-seq) maps from hundreds of single cells in aggregate closely resemble accessibility profiles from tens of millions of cells and provide insights into cell-to-cell variation. Accessibility variance is systematically associated with specific trans-factors and cis-elements, and we discover combinations of trans-factors associated with either induction or suppression of cell-to-cell variability. We further identify sets of trans-factors associated with cell-type-specific accessibility variance across eight cell types. Targeted perturbations of cell cycle or transcription factor signalling evoke stimulus-specific changes in this observed variability. The pattern of accessibility variation in cis across the genome recapitulates chromosome compartments 10 de novo, linking single-cell accessibility variation to three-dimensional genome organization. Single-cell analysis of DNA accessibility provides new insight into cellular variation of the 'regulome'.
Heterogeneity within cellular populations has been evident since the first microscopic observations of individual cells. Recent proliferation of powerful methods for interrogating single cells [4] [5] [6] [7] [8] has allowed detailed characterization of this molecular variation, and provided deep insight into characteristics underlying developmental plasticity 1, 2 , cancer heterogeneity 3 , and drug resistance 11 . In parallel, genome-wide mapping of regulatory elements in large ensembles of cells have unveiled substantial variation in chromatin structure across cell types, particularly at distal regulatory regions 12 . In particular, methods for probing genome-wide DNA accessibility have proven extremely effective in identifying regulatory elements across a variety of cell types 13 and quantifying changes that lead to both activation or repression of gene expression. Given this broad diversity of activity within regulatory elements when comparing phenotypically distinct cell populations, it is reasonable to hypothesize that heterogeneity at the single-cell level extends to accessibility variability within cell types at regulatory elements. However, the lack of methods to probe DNA accessibility within individual cells has prevented quantitative dissection of this hypothesized regulatory variation.
We have developed a single-cell assay for transposase-accessible chromatin (scATAC-seq). ATAC-seq is an ensemble measure of open chromatin that uses the prokaryotic Tn5 transposase 14, 15 to tag regulatory regions by inserting sequencing adapters into accessible regions of the genome. In scATAC-seq, individual cells are captured and assayed using a programmable microfluidics platform (Fluidigm) with methods optimized for this task (Fig. 1a , Extended Data Fig. 1 and Supplementary Discussion). After transposition and PCR on the integrated fluidics circuit (IFC), libraries were collected and PCR amplified with cell-identifying barcoded primers. Singlecell libraries were then pooled and sequenced on a high-throughput sequencing instrument. Using single-cell ATAC-seq, we generated DNA accessibility maps from 254 individual GM12878 lymphoblastoid cells. Aggregate profiles of scATAC-seq data closely reproduce ensemble measures of accessibility profiled by DNase-seq and ATAC-seq generated from ,10 7 or ,10 4 cells, respectively (Fig. 1b, c and Extended Data Fig. 2a ). Data from single cells recapitulate several characteristics of bulk ATAC-seq data, including fragment-size periodicity corresponding to integer multiples of nucleosomes, and a strong enrichment of fragments within regions of accessible chromatin (Extended Data Fig. 2b, c) . Microfluidic chambers generating low library diversity or poor measures of accessibility, which correlate with empty chambers or dead cells, were excluded from further analysis ( Fig. 1d and Extended Data Fig. 2d-l) . Chambers passing filter yielded an average of 7.3 3 10 4 fragments mapping to the nuclear genome. We further validated the approach by measuring chromatin accessibility from a total of 1,632 IFC chambers representing three tier 1 ENCODE cell lines 16 (H1 human embryonic stem cells (ES cells), K562 chronic myelogenous leukaemia and GM12878 lymphoblastoid cells), as well as from V6.5 mouse ES cells, EML 1 cells (mouse haematopoietic progenitors), TF-1 cells (human erythroblast), HL-60 cells (human promyeloblasts) and BJ fibroblasts (human foreskin fibroblasts).
Because regulatory elements are generally present at two copies in a diploid genome, we observe a near digital (0 or 1) measurement of accessibility at individual elements within individual cells (Extended Data Fig. 3a ). For example, within a typical single cell we estimate a total of 9.4% of promoters are represented in a typical scATAC-seq library (Extended Data Fig. 3b-d) . The sparse nature of scATAC-seq data makes analysis of cellular variation at individual regulatory elements impractical. We therefore developed an analysis infrastructure to measure regulatory variation using changes of accessibility across sets of genomic features (Fig. 2a, b) . To quantify this variation we first choose a set of open chromatin peaks, identified using the aggregate accessibility track, which share a common characteristic (such as transcription factor binding motif, ChIP-seq peaks or cell cycle replication timing domains). We then calculate the observed fragments in these regions minus the expected fragments, downsampled from the aggregate profile, within individual cells. To correct for bias, we divide this by the root mean square of fragments expected from a background signal constructed to estimate technical and sampling error within single-cell data sets (Methods and Extended Data Fig. 4) . Hereafter, we refer to this metric as 'deviation'. Finally, for any set of features, we also calculate an overall 'variability' score across all cells (Fig. 2b) , a metric of excess variance over the background signal.
We first focused our analysis on K562 myeloid leukaemia cells, a cell type with extensive epigenomic data sets 17, 18 . To comprehensively characterize variability associated with trans-factors within individual K562 cells, we computed variability across all available ENCODE ChIP-seq, transcription factor motifs and regions that differed in replication timing (as determined from Repli-Seq data sets 19 ) (Fig. 2c, d ). We found measures of cell-to-cell variability were highly reproducible across biological replicates (Extended Data Fig. 5 ). As expected from proliferating cells, we find increased variability within different replication timing domains, representing variable ATAC-seq signal associated with changes in DNA content across the cell cycle. In addition, we discover a set of trans-factors associated with high variability. These factors include sequencespecific transcription factors, such as GATA1/2, JUN and STAT2, and chromatin effectors, such as BRG1 (also known as SMARCA4) and P300 (also known as EP300). Immunostaining followed by microscopy or flow cytometry ( This analysis suggests that high-variance trans-factors are variable independent of the cell cycle ( Fig. 2f and Extended Data Fig. 6e-g ). The remaining PCs show contributions from several transcription factors, suggesting that variance across sets of trans-factors represent distinct regulatory states in individual cells.
We hypothesized that variation associated with different trans-factors can synergize, either through cooperative or competitive binding, to induce or suppress site-to-site variability in chromatin accessibility. For example, the most variant factors in K562 cells, GATA1 and GATA2, display expression heterogeneity and also bind an identical consensus sequence GATA, suggesting these factors may compete for access to DNA sequences. In support of this hypothesis, we find regulatory elements with both GATA1 and GATA2 ChIP-seq signals show increased variability in accessibility, whereas sites with only GATA1 or GATA2 show substantially less variability ( Fig. 2g and Extended Data Fig. 6h ). In contrast, we find no substantial change in variability of GATA1 binding sites that co-occur with JUN or CEBPB (Extended Data Fig. 6i ). We also find peaks unique to GATA1 binding are significantly more accessible than peaks unique to GATA2 (Extended Data Fig. 6k-l) supporting the hypothesis that GATA1, an activator of accessibility, competes with GATA2 to induce singlecell variability. Extending this analysis to all transcription factor ChIPseq data sets revealed a trans-factor synergy landscape for accessibility variation ( Fig. 2g and Extended Data Fig. 6j ). For example, chromatin accessibility variance associated with GATA2 binding is significantly enhanced when the same region could also be bound by GATA1, TAL1 or P300. In contrast, CTCF, SUZ12, and ZNF143 appear to act as general suppressors of accessibility variance, unless associated with proximal binding of ZNF143 or SMC3, the latter a cohesin subunit involved in chromosome looping 18, 20 . Thus, single cell accessibility profiles nominate distinct trans-factors that, in combination, induce or suppress cell-to-cell regulatory variation.
To validate our ability to detect changes in accessibility variance, we used chemical inhibitors to modulate potential sources of cell-cell variability. Inhibition of cyclin-dependent kinases 4 and 6 (CDK4/ 6), essential components of the cell cycle, caused a marked reduction of variability within peaks associated with DNA replication timing domains (Repli-Seq) (Fig. 3a) . The addition of inhibitors of JUN or BCR-ABL kinases (JNKi and imatinib, respectively) increased G1/Sassociated variability suggesting an increase in the subpopulation of G1/S cells, which was validated with flow cytometry (Extended Data  Fig. 7 ). JUN variability was significantly gained in response to JNKi but not imatinib treatment, suggesting that high-variance trans-factors can also be specifically and pharmacologically modulated. Tumour necrosis factor (TNF) treatment of GM12878 cells specifically modulated accessibility variability at NF-kB sites (Fig. 3b) , consistent with the known stochastic and oscillatory property of nuclear shuttling in 
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We observe that trans-factors associated with high variability are generally cell-type specific. Hierarchical bi-clustering of single-cell deviations generated from three cell lines reveals cell-type specific sets of transcription factor motifs associated with high variability (Fig. 3c ). This analysis also shows cells from different biological replicates cluster with their cell type of origin (with a single exception), suggesting scATAC-seq can also be used to deconvolve heterogeneous cellular mixtures. Systematic analysis of all assayed cell types identified highvariance trans-factor motifs that are generally unique to specific cell types ( Fig. 3d and Extended Data Fig. 8a ). For example, regions associated with GATA transcription factors are most variant in K562 cells, whereas regions associated with master pluripotency transcription factors Nanog and Sox2 are most variant in mouse ES cells, consistent with previous observations of expression variation of these factors 22, 23 . We also find high variability of GATA1 and PU.1 (SPI1) binding accessibility in EML cells, a cell type previously shown to have .200-fold GATA1 and .15-fold PU.1 expression differences within clonal cellular subpopulations 1 . The complete set of identified highvariance trans-factors contains a number of transcription factors previously reported to dynamically localize into the nucleus, including NFkB, JUN and ETS/ERG 21, 24, 25 , suggesting that temporal fluctuations in transcription factor concentration may be driving observed chromatin accessibility heterogeneity. Finally, we find BJ fibroblasts and HL-60 cells exhibit less variance among this set of annotated trans-factor motifs, suggesting differences in the global levels of trans-factor variability across cell lines. Specific chromatin states and histone modifications 26 are also sometimes associated with accessibility variation in single cells (Extended Data Fig. 8b , c). Overall these findings suggest that trans-factors promote cell-type specific chromatin accessibility variation genome-wide.
Patterns of variation in accessibility along the linear genome in individual cells reveal an unexpected connection to higher-order chromosome folding. We calculated single-cell deviations within sliding windows across the genome, each encompassing a fixed number of peaks (n 5 25) (Fig. 4a) . We determined which windows co-varied within individual cells by calculating the co-correlation of each window across all others within the same chromosome within individual cells (Extended Data Fig. 9a, b) . We further enhanced this co-correlation matrix using a secondary correlation analysis using methods similar to those used in chromosome conformation studies 10 (Methods). The resulting matrix, which identifies pairs of positions in the genome GATA2  COREST  COREST  P300  TBLR1  GATA1  TAL1  ARID3A  MAFF  MAFK  STAT1  INI1  SIRT6  ZNF274  BRG1  CEBPB  STAT2  ATF  CJUN  POL2  BDP1  POL3  CBX8  CBX2  SMC3  SUZ12 
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G2015 Macmillan Publishers Limited. All rights reserved where accessibility co-varies within individual cells, yields megabasescale correlation domains highly concordant with previously observed chromosome compartments 27 ( Fig. 4b-d and Extended Data Fig. 9c -i) (R 5 0.61 for chromosome 1). These data provide independent biological validation of large-scale compartmentalization of higher-order chromatin structure 10, 27 . Moreover, these results suggest that higherorder chromatin interactions may drive regulatory variability in cis (elements that are proximal together tend to be accessible together). Thus, ensemble chromosome conformation data may arise in part from the statistical properties of single cell variation in co-regulated accessibility, a hypothesis also supported by single-cell fluorescent in situ hybridization (FISH) measurements of interactions between DNA loci 28 . Using scATAC-seq, we dissected single-cell epigenomic heterogeneity and linked cis-and trans-effectors to variability in accessibility profiles within individual epigenomes. We identify trans-factors associated with increased accessibility variance, which we call highvariance trans-factors. Additionally, other trans-factors such as CTCF appear to buffer variability, perhaps by providing a stable anchor of chromatin accessibility or insulator function that dampens potential fluctuations. Conversely, co-occurance with other factors such as P300 appears to amplify variability, perhaps due to synergistic interactions. TEAD1  MYCN  YY1  RREB1  NFKB1  RELA  REL  CTCF  ELF1  GATA2  GATA4  GATA1  GATA3  TAL1  NFE2  FOSL1  JUNB  FOSL2  JUND  JUN  FOS  BATF  RFX1  RFX2  RUNX1  SPI1  ZEB1  EHF  ERG  ETS1  FLI1  FEV  RUNX2  BACH1  NFE2L2  NR4A2  ESRRA  ESRRB  NANOG 
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We envision that future studies will enhance the utility of scATACseq by further improving the recovery of DNA fragments, increasing throughput, and refining methods of data analysis (Supplementary Discussion). Improvements to throughput and new statistical tools will enable single-cells to be partitioned by cell-state and analysed in aggregate to find the individual peaks that drive variability (Extended Data Fig. 10 ). In addition, we anticipate scATAC-seq may be paired with existing approaches in microscopy and single-cell RNA-seq to provide opportunities for systems analysis of individual cells. Such an approach will link regulatory variation to details of phenotypic variation, providing new insights into the molecular underpinnings of cellular heterogeneity. We believe scATAC-seq will also enable the interrogation of the epigenomic landscape of small or rare biological samples allowing for detailed, and potentially de novo, reconstruction of cellular differentiation or disease at the fundamental unit of investigation-the single cell. Extended Data LETTER RESEARCH 5   TBLR1  P300  COREST  COREST  GATA2  GATA1  TAL1  ARID3A  MAFF  MAFK  STAT1  SIRT6  INI1  ZNF274  BRG1  CEBPB  STAT2  ATF  CJUN  POL2  BDP1  POL3  CBX8  CBX2  SMC3  SUZ12  CTCF h, i, Venn diagrams showing variability of GATA1 and/or GATA2 (h), cJUN and/or GATA2 and CEBPB and/or GATA2 (co-)occurring ChIP-seq sites (i). j, The 2log 10 (P values) of calculated changes in co-occurring ChIP-seq sites shown in Fig. 2g . k, Distribution of accessibility among GATA1 only, GATA2 only, and shared sites. l, Mean accessibility from GATA1 only, GATA2 only, and shared sites in k, error bars represent one standard deviation generated by bootstrapping ChIP-seq peaks. Chromosome   chr1  chr2  chr3  chr4  chr5  chr6  chr7  chr8  chr9  chr10  chr11  chr12  chr13  chr14  chr15  chr16  chr17  chr18  chr19  chr20  chr21  chr22 Chromosome   chr1  chr2  chr3  chr4  chr5  chr6  chr7  chr8  chr9  chr10  chr11  chr12  chr13  chr14  chr15  chr16  chr17  chr18  chr19  chr20  chr21  chr22 RESEARCH LETTER
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